Long-term neuropathy and quality of life in colorectal cancer patients treated with oxaliplatin containing adjuvant chemotherapy.
CONCLUSIONS: Neuropathy following oxaliplatin containing adjuvant chemotherapy is present in two-thirds, years after cessation, and impairs some QOL scales. There is no difference in severity of acute or long-term neuropathy between CAPOX and FOLFOX treated and QOL is similar. No seasonal variation in neuropathy was noted.
PMID: 30638100 [PubMed - as supplied by publisher]
Source: Acta Oncologica - Category: Cancer & Oncology Authors: Soveri LM, Lamminmäki A, Hänninen UA, Karhunen M, Bono P, Osterlund P Tags: Acta Oncol Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Chemotherapy | Colorectal Cancer | Eloxatin | Neurology | Peripheral Neuropathy | Xeloda